Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • CONGRESSIONAL RATINGS
        • PORKER OF THE MONTH
        • PRESS RELEASES
        • COMMENTARY
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • Earmark Database
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Biopharmaceuticals

Healthcare, Big Government, Biopharmaceuticals, General Waste, International, Pharmaceuticals

The IPI – Are We All Socialists Now?

February 1, 2020 Elizabeth Wright

Adopting these policies would validate socialized medicine schemes like price controls and rationing.

Healthcare, Big Government, Biopharmaceuticals, General Waste, Intellectual Property, Medicaid, Medicare, Medicare/aid, Property Rights

Sen. Elizabeth Warren Offers More Dangerous Healthcare Ideas

January 11, 2020 Elizabeth Wright

Essentially it is Speaker Nancy Pelosi’s (D-Calif.) socialistic drug discount plan, H.R. 3, on steroids.

Healthcare, Biopharmaceuticals, Medicaid, Medicare, Medicare/aid, Pharmaceuticals

CBO Releases the “Savings” Expected from Speaker Pelosi’s Drug Pricing Bill

December 7, 2019 Elizabeth Wright

H.R. 3 exerts so much government authority over the pharmaceutical industry.

Healthcare, Biopharmaceuticals, CMS

Big Pharma DOES Negotiate Drug Prices

April 1, 2017 Elizabeth Wright

On March 7, 2017, President Trump tweeted he was “working on a new system where there will be competition in the Drug Industry.  Pricing for the American people will come way down.”  The next day, in a meeting with Representatives Elijah Cummings (D-Md.) and Peter Welch (D-Vt.) , the president reiterated that he wanted to […]

340B, Biopharmaceuticals, General Waste, Healthcare

What is the 340B Program and Why You Need to Care

May 15, 2014 Elizabeth Wright

Problems in the 340B drug discount program are growing and costs are increasing due as more entities participate in the program.

Biopharmaceuticals, Biosimilars, Budget, General Waste, Healthcare, Obamacare, Pharmaceuticals

Salvage the Good from the Healthcare Debacle

August 1, 2006 Thomas Schatz

The healthcare reform juggernaut, arguably the most radical attempt to remake the economy and the nation’s healthcare infrastructure in history, was supposed to have flown through Congress before the August recess with nary a peep.  Instead, as Americans have gotten wind of its alarming provisions and exorbitant costs, the plan appears to be fizzling fast in the summer heat.

Posts pagination

Previous 1 … 3 4

Search

Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

  • MISSION/HISTORY
  • DIRRECTORS/STAFF
  • SUPPORT
  • FINANCIAL INFORMATION
  • CONTACT US
  • CCAGW
  • 1-800-USA-DEBT ®
  • MEDIA@CAGW.ORG
  • 317 MASSACHUSETTS AVENUE, N.E.
    SUITE 300
    WASHINGTON, D.C. 20002

© Citizens Against Government Waste